معرفی
Scott Stuart Maxwell is an Adjunct Research Fellow in Diabetes at Monash University, actively contributing to research in epigenetics, bioinformatics, and diabetic complications. His work spans molecular mechanisms of gene regulation, DNA methylation, and single-cell genomics in the context of diabetes and its associated diseases.
- Institution: Monash University
- Department: Diabetes
- Academic Rank: Research Fellow (Adjunct)
- Email: Scott.Maxwell1@monash.edu
- ORCID: https://orcid.org/0000-0002-7801-0714
Dr. Maxwell completed his PhD in Epigenetics/Bioinformatics, focusing on the biochemical characterisation of MeCP2 in the brain. His research has significantly contributed to understanding epigenetic regulation in diabetes, particularly in diabetic nephropathy, cardiovascular disease, and beta-cell dysfunction.
His research interests include:
- Epigenetics and DNA Methylation
- Bioinformatics and RNA-Seq
- Diabetic Complications (nephropathy, retinopathy, cardiovascular)
- Gene Regulation and Chromatin Remodeling
- Single-Cell Genomics
- Molecular Mechanisms of Type 1 and Type 2 Diabetes
The most recent articles (2021–2024) highlight a strong focus on epigenetic biomarkers, inflammatory pathways in diabetic kidney disease, beta-cell regeneration, and the role of methyltransferases in endothelial dysfunction. His work integrates molecular biology with clinical implications, aiming to identify novel therapeutic targets and early detection markers for diabetes complications.
Scientific recognition includes extensive media coverage (picked up by over 60 news outlets), social media engagement (hundreds of X posts), and Mendeley readership, though no formal awards are listed.
Dr. Maxwell serves as a Chief Investigator on active grants, such as the project on cytosine methylation in diabetic nephropathy progression (2021–2023), and is accepting PhD students, indicating an active mentoring role. His collaborative network includes leading researchers in diabetes and epigenetics at Monash and internationally.
He is involved in a research lab or team focused on epigenetic mechanisms in metabolic disease, likely within the Diabetes department at Monash University, contributing to interdisciplinary studies on gene regulation in high-impact journals.
